Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Correction to: Letter to the Editor: A Favorable Benefit–Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment,by Qin Hum Gene Ther 2023;34(7-8):339–340;doi: 10.1089/hum.2023.028